We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Low-Calorie Cranberry Juice Shown to Lower Cardiovascular Disease Risk

By LabMedica International staff writers
Posted on 14 Jul 2015
Print article
Image: Cranberries grown and harvested in Massachusetts (USA). Cranberry juice was found to lower risk of developing cardiovascular disease (Photo courtesy of Wikimedia Commons).
Image: Cranberries grown and harvested in Massachusetts (USA). Cranberry juice was found to lower risk of developing cardiovascular disease (Photo courtesy of Wikimedia Commons).
Supplementing the diet with low-calorie cranberry juice (LCCJ) reduces the chances of developing cardiovascular disease by lowering several risk factors including circulating triglycerides (TGs), C-reactive protein (CRP), glucose, and diastolic blood pressure (BP).

Investigators at the United States Department of Agriculture (Beltsville, MD, USA) and Ocean Spray Cranberries, Inc. (Lakeville-Middleborough, MA, USA) conducted a double-blind, placebo-controlled, parallel-arm study on 30 women and 26 men. For eight weeks the participants ate controlled diets supplemented with twice daily drinks of 240 milliters of LCCJ or a placebo beverage, containing 173 or 62 mg of phenolic compounds and 6.5 or 7.5 g of total sugar per 240 milliliter serving, respectively.

Results published in the April 22, 2015, online edition of the Journal of Nutrition revealed that fasting serum TGs were lower after consuming LCCJ and that the participants with higher baseline TG concentrations were more likely to experience a larger treatment effect. Other cardiovascular disease risk factors including serum C-reactive protein (CRP), diastolic blood pressure (BP), and fasting plasma glucose were lower for individuals consuming LCCJ than for individuals consuming the placebo beverage. Furthermore, LCCJ had a beneficial effect on homeostasis model assessment of insulin resistance for participants with high baseline values.

"At the start and end of the experiment, the researchers measured things like blood pressure, blood sugar levels, blood lipids, as well as C-reactive protein, a marker of inflammation," said contributing author Dr. Christina Khoo, director of research sciences at Ocean Spray Cranberries, Inc. "All of these measurements come together to tell a story. The worse off these numbers are in an individual, the more likely he or she will face a health condition like diabetes, heart disease, or stroke in the future. These findings suggest that polyphenols help to protect our bodies, and may be adept at keeping a large number of ailments at bay. Luckily for us, a rich source of polyphenols is only a glass of cranberry juice away. Among the commonly consumed fruits in our diets, cranberries boast some of the highest levels of polyphenols—more than apples, blueberries, grapes, or cherries."

The investigators suggested that individuals drinking two glasses of LCCJ per day could experience up to a 10% percent lower risk of heart disease and a 15% percent lower risk of stroke.

Related Links:

United States Department of Agriculture
Ocean Spray Cranberries, Inc. 


Gold Member
Turnkey Packaging Solution
HLX
Unit-Dose Packaging solution
HLX
New
Monkeypox Test
Monkeypox Virus Rapid Antibody Test
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.